Company Details

Innocrin Pharmaceuticals
Overview
Develops novel oral inhibitors for prostate and hormonally-driven cancers.
Total Raised
$28 M
Rounds
1
Links
Verticals
Biotechnology
Health Care
Medical
Pharmaceutical
Investment History
Series D
Apr 2015
$28M